Research funder · United States

Michael J. Fox Foundation for Parkinson's Research

Non-profit organization in the USA

michaeljfox.org

Grants since 2016: 1 275
Awarded, last 5 years (where amounts are published): —
Funded works, last 5 years: 3 085
Funded works, all time: 6 716

Grants

2022 · research · Cellular Phenotyping in Human iPSCS from the PPMI Cohort

Defining Mechanisms in Different Brain Cells that Drive Progression in Parkinson’s Disease

Sonia Gandhi · Ucl & The Francis Crick Institute

2022 · research · Fall 2021 RFP: Outcome Measures

Pet Imaging to Determine Regional and Temporal Trajectories of Reactive Astrocytosis in Parkinson’s Disease

Matthias Brendel · LMU Klinikum

2022 · research · Fall 2020 RFA: Therapeutic Pipeline Program-Pre-Clinical

Targeting Colony-stimulating Factor 1 Receptor (CSF1R) to Modify Disease Progression in Preclinical Experimental Models of Parkinson’s Disease

Arthi Kanthasamy · University of Georgia

2022 · research · Translational Pipeline Program

Prevention of Dementia in GBA-associated Parkinson’s Disease

Kathrin Brockmann · Department Of Neurodegeneration, Hertie-institute For Clinical Brain Research

2022 · research · Expanding Biological Understanding of Parkinson's Disease

Deep Phenotyping of Parkinson's Disease Relevant Mitochondrial and Autophagic Mechanisms in Human iPSC-derived Neural Cells

Lalitha Madhavan · University of Arizona

2022 · research · Fall 2021 RFP: Outcome Measures

Use of Integrated, Multi-omic Data Analysis for Screening and Treatment of Parkinson’s Disease

Bratislav Misic · McGill University

2022 · research · Research Grant

Development of Irreversible PET Radiotracers for Glucocerebrosidase

Christopher Peter Phenix · University of Saskatchewan

2022 · research · Spring 2022 RFA: Therapeutic Pipeline Program Pre-Clinical

Assessing the Effects of USP30 Inhibitors on the Removal of Damaged Mitochondria in Nerve Cells

Bahareh (Spring) Behrouz · Vincere Biosciences Inc

2022 · research · Spring 2022 RFA: Target Advancement Program - Tool Generation

Design and testing of a FRET sensor for Parkin activity

Michael Clague · University of Liverpool

2022 · research · Therapeutic Pipeline Program

Developing Selective Ion Channel Blockers that Reduce Neuroinflammation in Parkinson’s Disease

Rita Balice-Gordon · Sanofi, Inc.

2022 · research · Research Resources Imaging Program

Developing Actionable Machine Learning (AML) Methods for Diagnosing, Monitoring and Treating Parkinson’s Disease

Chandrajit Bajaj · The University of Texas at Austin

2022 · research · Fall 2021 RFP: Accelerating Early Proof-of-Concept Testing of Promising PD Therapies

Using “Nanobodies” to Prevent Formation of Intracellular Alpha-synuclein Aggregates

Jeffrey H. Kordower · Rush University Medical Center

2022 · research · Parkinson’s Pathway Molecular Data Analysis Program

Mining for Protein Aberrations in Parkinson’s Disease Using Large-Scale Protein Databases

Eleanor Therese Coffey · Turku Centre For Biotechnology, Åbo Akademi University And University Of Turku

2021 · research · Therapeutic Pipeline Program

Dietary Interventions to Slow and Improve Parkinson’s Symptoms by Restructuring the Gut Microbiome and Decreasing Inflammation

Brit Mollenhauer · Universitätsmedizin Göttingen

2021 · research · Fall 2021 RFP: Outcome Measures

Use of Image-enhancement Techniques to Assess Anatomical Changes in Parkinson’s Disease

Jacob Hesterman · Invicro (United States)

2021 · research · Target Advancement Program

Validating Genetic Modifiers that Affect Disease Onset in People with LRRK2 Mutations

Jordan Follett · University of Florida

2021 · research · Analysis of Patient-Reported Outcomes from Fox Insight

Characterizing Impairment Trajectories in People with Parkinson’s Disease

Farren Basil Shaw Briggs · Case Western Reserve University

2021 · research · Aligning Science Across Parkinson's

Basal Ganglia Networks in Parkinson's Disease

Peter L. Strick · University of Pittsburgh

2021 · research · Fall 2021 RFP: Expanding Biological Understanding of PD

Studying How Defects in Autophagy Contribute to the Aggregation of Alpha-synuclein in Neurons with LRRK2 Mutations

Clemens-Alexander Boecker · Universitätsmedizin Göttingen

2021 · research · Outcome Measures

Development of a Method for Assessing the Effectiveness of Alpha-synuclein Immunotherapy

Jean-Cosme Dodart · Vaxxinity

2021 · research · Fall 2021 RFP: Accelerating Early Proof-of-Concept Testing of Promising PD Therapies

Development of a Small-molecule Inhibitor Targeting Intracellular Alpha-synuclein Pathology

Elpida Tsika · AC Immune (Switzerland)

2021 · research · Research Grant

Development of Selective PET Imaging Agents for Alpha-synuclein and Tau

Neil Vasdev · Centre for Addiction and Mental Health

2021 · research · Fall 2021 RFP: Accelerating Early Proof-of-Concept Testing of Promising PD Therapies

Reprogramming the Brain’s Non-neuronal Support Cells to Generate Functional Dopamine-producing Neurons

William C. Mobley · University of California San Diego

2021 · research · Target Advancement Program

Targeting the Chemical Modification of DNA to Suppress Neurodegeneration in Parkinson’s Disease

Patrik Brundin · Van Andel Institute

2021 · research · Access to Data and Biospecimens

Assessing Inhibition of a Protein of the “Complement System” to Reduce Brain Inflammation and Neuronal Loss in People with Parkinson’s Disease

Manoj Kumar Pandey · Cincinnati Children's Hospital Medical Center

2021 · research · Therapeutic Pipeline Program

Brain-penetrating Antisense Oligonucleotide to Down-regulate Alpha-synuclein

Fazel Shabanpoor · Florey Institute of Neuroscience and Mental Health

2021 · research · Fall 2021 RFP: Accelerating Early Proof-of-Concept Testing of Promising PD Therapies

Using Nanobodies and Peptide Mimetics to Stabilize and Activate Mutant GBA

Nicoletta Plotegher · University of Padua

2021 · research · Aligning Science Across Parkinson's

Engineering Research-enabling Cells to Fuel Mechanistic Studies of Parkinson’s Disease

Mark R. Cookson · National Institute on Aging

2021 · research · Research Grant

Preclinical Testing of a Novel Tracer for Imaging Alpha-synuclein Aggregates

Armin Giese · Modag Gmbh

2021 · research · Therapeutic Pipeline Program

Development of Compounds that Destroy Alpha-Synuclein Aggregates for the Treatment of Parkinson’s Disease

Antje Willuweit · Priavoid Gmbh

2021 · research · Parkinson's Pathway Biomarkers

Phospho-proteome Analysis of PBMCs in LRRK2 Mutation Carriers: Expansion & Validation of Findings of the Barcelona LRRK2 Biorepository

Rubén Fernández-Santiago · Idibaps, Hospital Clinic, University Of Barcelona

2021 · research · Biomarkers